Literature DB >> 2563932

Neuropsychological side effects of beta-blockers.

J E Dimsdale1, R P Newton, T Joist.   

Abstract

Fifty-five studies of cognitive side effects of beta-blockers were reviewed. Many of the studies were limited by small sample size, use of drugs out of the range of normal administration, failure to control for known confounders for neuropsychological evaluation, or lack of a crossover design. As a result, one needs caution in drawing conclusions on this topic. Nevertheless, given the widespread use of beta-blockers and the frequent allegations about their relative side effect profiles, it is appropriate to summarize the results of these disparate studies. Across all beta-blockers and all cognitive domains, the drugs led to improved functioning in 16% of observations and worsened functioning in 17%, with no significant effect in the rest. Memory, learning, and abstraction have been studied less frequently. The perceptual motor cognitive domain was the most widely studied and was frequently affected by these drugs. There was no consistent evidence of a trend for lipophilic drugs to impair this domain more than lipophobic drugs. There is some evidence that these drugs have a positive effect on complex task performance. The drugs also seem to increase sedation; however, in these studies there was no evidence for a differential effect across lipophilic vs lipophobic drugs.

Mesh:

Substances:

Year:  1989        PMID: 2563932

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

Review 2.  An approach to drug induced delirium in the elderly.

Authors:  K Alagiakrishnan; C A Wiens
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

Review 3.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

Review 4.  Pharmacologic considerations in the positioning of beta-blockers in antihypertensive therapy.

Authors:  Domenic A Sica; Henry R Black
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

Review 5.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 6.  Do Risk Prediction Models for Postoperative Delirium Consider Patients' Preoperative Medication Use?

Authors:  Gizat M Kassie; Tuan A Nguyen; Lisa M Kalisch Ellett; Nicole L Pratt; Elizabeth E Roughead
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

Review 7.  Beta-blockers for congestive heart failure: what is the current consensus?

Authors:  R T Tsuyuki; F A McAlister; K K Teo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

8.  Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension.

Authors:  E J Pérez-Stable; T J Coates; R B Baron; B S Biró; W W Hauck; K S McHenry; P S Gardiner; D Feigal
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

Review 9.  Drug-induced cognitive impairment. Defining the problem and finding solutions.

Authors:  J D Bowen; E B Larson
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

10.  CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.

Authors:  A L van Steveninck; M S Pieters; H C Schoemaker; D D Breimer; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.